Key Principles and Recommended Regimens for First-line Antiretroviral Therapy

  • Author: Paul E. Sax, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 2/20/19 (What's New)

Summary

  • Fixed-dose formulations of NRTI pairs are available for:
    • Abacavir/Lamivudine
      Emtricitabine/Tenofovir DF
        Emtricitabine/Tenofovir Alafenamide
          Comparison of Emtricitabine/Tenofovir DF With Abacavir/Lamivudine
            Safety Considerations With Tenofovir DF and Abacavir
              Tenofovir DF
                Abacavir
                Comparison of Tenofovir DF and Tenofovir AF When Each Is Coformulated With Cobicistat/Elvitegravir/Emtricitabine

                Action required

                Keywords: Initial Antiretroviral Therapy, Tropism

                ©2018 Clinical Care Options, LLC. All Rights Reserved.

                The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.